Jaguar Animal Health - 11 Year Stock Price History | JAGX

Historical daily share price chart and data for Jaguar Animal Health since 2015 adjusted for splits and dividends. The latest closing stock price for Jaguar Animal Health as of January 23, 2026 is 0.76.

The all-time high Jaguar Animal Health stock closing price was 1000000.00 on May 12, 2015.
The Jaguar Animal Health 52-week high stock price is 25.75, which is 3288.2% above the current share price.
The Jaguar Animal Health 52-week low stock price is 0.64, which is 15.8% below the current share price.
The average Jaguar Animal Health stock price for the last 52 weeks is 5.25.

Jaguar Animal Health Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	0.9345	0.9980	1.4300	0.6910	0.7649	-17.84%
2025	6.6448	27.2500	32.0000	0.9310	0.9310	-96.31%
2024	103.7184	226.5000	477.0000	21.5000	25.2500	-88.85%
2023	1806.9420	9900.0000	13050.0000	225.0000	226.5000	-97.69%
2022	41291.9861	120375.0000	120375.0000	9450.0000	9787.5000	-91.63%
2021	485189.4841	600750.0000	1000000.0000	115875.0000	117000.0000	-57.46%
2020	168472.5375	265612.0000	361125.0000	64125.0000	275062.0000	1.75%
2019	700146.5437	1000000.0000	1000000.0000	185625.0000	270338.0000	-72.97%
2018	1000000.0000	1000000.0000	1000000.0000	1000000.0000	1000000.0000	0.00%
2017	1000000.0000	1000000.0000	1000000.0000	1000000.0000	1000000.0000	0.00%
2016	1000000.0000	1000000.0000	1000000.0000	1000000.0000	1000000.0000	0.00%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$0.003B	$0.012B
Jaguar Health, Inc. is a natural-products pharmaceuticals company. It focused on developing and commercializing novel, sustainably derived gastrointestinal products for both human prescription use and animals. The company through its subsidiary Napo Pharmaceuticals Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals. Its product pipeline consists of Mytesi(R), Canalevia(TM), Equilevia(TM) and Neonorm (TM). Jaguar Health Inc., formerly known as Jaguar Animal Health Inc., is based in San Francisco, United States.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$91.260B	34.66
Zoetis (ZTS)	United States	$54.668B	19.57
Takeda Pharmaceutical (TAK)	Japan	$51.834B	10.58
Daiichi Sankyo, - (DSNKY)	Japan	$37.584B	18.72
BeOne Medicines - (ONC)	Switzerland	$37.211B	197.28
Sandoz Group AG (SDZNY)	Switzerland	$35.741B	0.00
United Therapeutics (UTHR)	United States	$20.191B	17.77
Merck (MKKGY)	Germany	$19.464B	12.00
Shionogi (SGIOY)	Japan	$16.929B	15.55
IPSEN (IPSEY)	France	$13.608B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.578B	32.58
Ionis Pharmaceuticals (IONS)	United States	$13.004B	0.00
Summit Therapeutics (SMMT)	United States	$12.716B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$10.912B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.411B	0.00
Ono Pharmaceutical (OPHLF)	Japan	$6.967B	21.19
Stevanato Group S.p.A (STVN)	Italy	$5.230B	29.27
Crinetics Pharmaceuticals (CRNX)	United States	$5.046B	0.00
Corcept Therapeutics (CORT)	United States	$4.626B	49.98
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.547B	0.00
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.209B	19.99
Indivior (INDV)	United States	$4.122B	16.82
NewAmsterdam Pharma (NAMS)	Netherlands	$3.778B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$3.397B	0.00
Hypermarcas (HYPMY)	Brazil	$2.977B	20.43
Catalyst Pharmaceuticals (CPRX)	United States	$2.898B	9.25
Dyne Therapeutics (DYN)	United States	$2.571B	0.00
Soleno Therapeutics (SLNO)	United States	$2.275B	0.00
Ocular Therapeutix (OCUL)	United States	$2.188B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Guardian Pharmacy Services (GRDN)	United States	$1.932B	37.21
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$1.916B	22.70
Ardelyx (ARDX)	United States	$1.888B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.731B	0.00
Oruka Therapeutics (ORKA)	United States	$1.665B	0.00
Harrow (HROW)	United States	$1.647B	101.07
Enliven Therapeutics (ELVN)	United States	$1.530B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.438B	7.12
BioCryst Pharmaceuticals (BCRX)	United States	$1.431B	84.88
Relay Therapeutics (RLAY)	United States	$1.288B	0.00
Evotec AG (EVO)	Germany	$1.282B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.234B	0.00
Savara (SVRA)	United States	$1.225B	0.00
Aktis Oncology (AKTS)	United States	$1.097B	0.00
Cronos Group (CRON)	Canada	$1.061B	0.00
Theravance Biopharma (TBPH)	United States	$1.026B	43.06
ARS Pharmaceuticals (SPRY)	United States	$1.009B	0.00
Xencor (XNCR)	United States	$0.913B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.851B	20.12
KalVista Pharmaceuticals (KALV)	United States	$0.810B	0.00
Nektar Therapeutics (NKTR)	United States	$0.755B	0.00
Esperion Therapeutics (ESPR)	United States	$0.751B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.671B	5.99
Bioventus (BVS)	United States	$0.664B	13.59
ProKidney (PROK)	United States	$0.653B	0.00
Altimmune (ALT)	United States	$0.574B	0.00
Lexeo Therapeutics (LXEO)	United States	$0.547B	0.00
Lyell Immunopharma (LYEL)	United States	$0.537B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.505B	0.00
Organogenesis (ORGO)	United States	$0.498B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.488B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.487B	0.00
Siga Technologies (SIGA)	United States	$0.476B	6.51
4D Molecular Therapeutics (FDMT)	United States	$0.455B	0.00
Nature's Sunshine Products (NATR)	United States	$0.432B	25.70
USANA Health Sciences (USNA)	United States	$0.412B	11.49
Aquestive Therapeutics (AQST)	United States	$0.395B	0.00
Cybin (HELP)	Canada	$0.376B	0.00
Akebia Therapeutics (AKBA)	United States	$0.361B	0.00
Protara Therapeutics (TARA)	United States	$0.320B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.312B	0.00
Larimar Therapeutics (LRMR)	United States	$0.305B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.298B	0.00
Avalo Therapeutics (AVTX)	United States	$0.292B	0.00
Profound Medical (PROF)	Canada	$0.289B	0.00
Fractyl Health (GUTS)	United States	$0.286B	0.00
Relmada Therapeutics (RLMD)	United States	$0.286B	0.00
OmniAb (OABI)	United States	$0.282B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.268B	0.00
Heron Therapeutics (HRTX)	United States	$0.260B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.256B	0.00
Journey Medical (DERM)	United States	$0.236B	0.00
MediWound (MDWD)	Israel	$0.227B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.223B	0.00
Galectin Therapeutics (GALT)	United States	$0.213B	0.00
Century Therapeutics (IPSC)	United States	$0.212B	0.00
AleAnna (ANNA)	United States	$0.192B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Minerva Neurosciences (NERV)	United States	$0.172B	0.00
Surrozen (SRZN)	United States	$0.168B	0.00
Context Therapeutics (CNTX)	United States	$0.166B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
VAXART, INC (VXRT)	United States	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.153B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.149B	0.00
Avita Medical (RCEL)	United States	$0.135B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.131B	0.00
Prelude Therapeutics (PRLD)	United States	$0.127B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.121B	0.00
Incannex Healthcare (IXHL)	Australia	$0.119B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.119B	0.00
Vivani Medical (VANI)	United States	$0.108B	0.00
Cassava Sciences (SAVA)	United States	$0.106B	0.00
Cardiol Therapeutics (CRDL)	Canada	$0.104B	0.00
Pyxis Oncology (PYXS)	United States	$0.101B	0.00
Korro Bio (KRRO)	United States	$0.101B	0.00
Champions Oncology (CSBR)	United States	$0.094B	39.71
Gain Therapeutics (GANX)	United States	$0.079B	0.00
PolyPid (PYPD)	Israel	$0.076B	0.00
Assertio Holdings (ASRT)	United States	$0.074B	0.00
Dominari Holdings (DOMH)	United States	$0.068B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.065B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Metagenomi Therapeutics (MGX)	United States	$0.063B	0.00
Rafael Holdings (RFL)	United States	$0.063B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.062B	0.00
Arch Biopartners (ACHFF)	Canada	$0.061B	0.00
Lipocine (LPCN)	United States	$0.061B	0.00
ElectroCore (ECOR)	United States	$0.060B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.059B	49.13
Nutriband (NTRB)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.047B	0.00
Talphera (TLPH)	United States	$0.047B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Plus Therapeutics (PSTV)	United States	$0.038B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.038B	0.00
Wellgistics Health (WGRX)	United States	$0.036B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.035B	0.00
SCYNEXIS (SCYX)	United States	$0.035B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.031B	0.00
TherapeuticsMD (TXMD)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.026B	0.00
Klotho Neurosciences (KLTO)	United States	$0.024B	0.00
Liminatus Pharma (LIMN)	United States	$0.021B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.019B	0.00
Traws Pharma (TRAW)	United States	$0.019B	0.02
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Inotiv (NOTV)	United States	$0.019B	0.00
Cosmos Health (COSM)	United States	$0.019B	0.00
Vyome Holdings (HIND)	United States	$0.018B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Vivos Therapeutics (VVOS)	United States	$0.017B	0.00
Tempest Therapeutics (TPST)	United States	$0.015B	0.00
Mannatech (MTEX)	United States	$0.015B	0.00
BioLineRx (BLRX)	Israel	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Nuvilex (PMCB)	United States	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
Mangoceuticals (MGRX)	United States	$0.008B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.007B	0.00
Redhill Biopharma (RDHL)	Israel	$0.007B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.007B	0.00
Aptorum Group (APM)	United Kingdom	$0.006B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.005B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.004B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.004B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
Grifols, S.A (GRFS)	Spain	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00